NASDAQ:LTRN | Cash Flow Statement | Lantern Pharma Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$7.07M
2026-03-31-$3.33M-$3.77M$4.25M
2025-12-31-$4.07M-$2.79M$1.00-$1.7M$526,459.00
2025-09-30-$4.18M
2025-06-30-$4.33M
2025-03-31-$4.54M-$4.38M$1,159.00$3.24M
2024-12-31-$5.88M-$3.97M$3,083.00$3.45M$0.00
2024-09-30-$4.51M
2024-06-30-$4.96M
2024-03-31-$5.44M$4,061.00-$3.07M$2,217.00-$556,168.00$54,716.00
2023-12-31-$4.19M$3,975.00-$3.39M$5,081.00$256,181.00
2023-09-30-$3.16M
2023-06-30-$4.75M
2023-03-31-$3.87M$3,418.00-$3.76M$8,876.00-$960,877.00
2022-12-31-$3.38M$2,760.00-$2.67M$6,955.00$602,861.00$0.00$0.00
2022-09-30-$2.26M
2022-06-30-$4.49M
2022-03-31-$4.12M$1,989.00-$3.33M$176,519.00$2.48M-$2.18M
2021-12-31-$3.54M$1,991.00-$2.04M$1.00-$233,958.00-$872,809.00
2021-09-30-$4.05M
2021-06-30-$2.32M
2021-03-31-$2.45M$1,343.00-$2.14M$64.29M
2020-12-31-$2.9M$1,093.00-$1.57M-$4,992.00-$261.00
2020-09-30-$1.7M
2020-06-30-$833,422.00
2020-03-31-$477,276.00$536.00-$703,048.00$105,265.00
2019-12-31-$675,167.00$536.00-$708,876.00$0.00$0.00
2019-09-30-$669,652.00
2019-06-30-$629,393.00
2019-03-31-$453,973.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$17.12M-$15.68M$1,715.00$11.06M$1.5M
2024-12-31-$20.78M-$17.81M$12,595.00$3.37M$66,710.00
2023-12-31-$15.96M$14,615.00-$14.35M$18,734.00-$930,210.00$499,997.00-$499,997.00
2022-12-31-$14.26M$10,081.00-$12.77M$27,844.00$179,268.00$2.48M-$2.18M
2021-12-31-$12.36M$6,761.00-$10.59M$15,499.00-$19.53M$939,666.00$63.42M
2020-12-31-$5.91M$3,388.00-$5.65M-$16,137.00$23.66M
2019-12-31-$2.43M$1,627.00-$2.13M-$5,717.00$2.92M